Inhibition Large Intestine Fluid/Electrolyte Absorption
DBCAT004130Pharmacologic class
A DrugBank category of 4 drugs. 2 of them are approved.
What you can answer from here — as of September 06, 2018
Which targets do Inhibition Large Intestine Fluid/Electrolyte Absorption share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account